AD is most commonly seen in the form of late-onset sporadic AD (LOAD) impacting individuals aged 65 and above, with the primary genetic risk factor identified as Apolipoprotein E allele ε4 (APOE ε4) [2]. This evidence concerns the gene APOE and Alzheimer disease.